Catherine Labbé
Impact in
Papers in
-
- Lung Cancer Treatments and Mutations 16
- Lung Cancer Diagnosis and Treatment 9
- Oncology 17
- Cancer Immunotherapy and Biomarkers 6
- Lung Cancer Research Studies 5
- Co-authors
- Natasha B. Leighl (11 shared papers)John David Rioux (5 shared papers)Kevin Jao (8 shared papers)Pascale Tomasini (6 shared papers)Owen A. Ross (16 shared papers)Frances Alice Shepherd (8 shared papers)Ramnik J. Xavier (3 shared papers)Philippe Goyette (3 shared papers)
- Journals
- Journal of Thoracic Oncology (5 papers)Parkinsonism & Related Disorders (4 papers)The Oncologist (3 papers)Clinical Lung Cancer (3 papers)PLoS ONE (3 papers)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Catherine Labbé
61 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 107
- Oncology 402
- Neurology 229
- Physiology 66
- Pulmonary and Respiratory Medicine 358
- Cancer Research 128
Countries citing papers authored by Catherine Labbé
This map shows the geographic impact of Catherine Labbé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Labbé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Labbé more than expected).
Fields of papers citing papers by Catherine Labbé
This network shows the impact of papers produced by Catherine Labbé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Labbé. The network helps show where Catherine Labbé may publish in the future.
Co-authors
The 25 scholars most cited alongside Catherine Labbé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 163 | |
| 2 | 2007 | 116 | |
| 3 | 2018 | 105 | |
| 4 | 2016 | 104 | |
| 5 | 1999 | 72 | |
| 6 | 2009 | 71 | |
| 7 | 2016 | 65 | |
| 8 | 2016 | 58 | |
| 9 | 2018 | 46 | |
| 10 | 2017 | 42 | |
| 11 | 2014 | 42 | |
| 12 | 2019 | 40 | |
| 13 | 2020 | 33 | |
| 14 | 2018 | 29 | |
| 15 | 2013 | 27 | |
| 16 | GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16. | 2013 | 25 |
| 17 | 2008 | 25 | |
| 18 | 2011 | 25 | |
| 19 | 2020 | 24 | |
| 20 | 2014 | 24 |
About Catherine Labbé
Catherine Labbé is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Neurology, Neurology and Genetics, having authored 68 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Diagnosis and Treatment (9 papers), Parkinson's Disease Mechanisms and Treatments (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Research Studies (5 papers), RNA regulation and disease (4 papers), Inflammatory Bowel Disease (4 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). The work is most often cited by research in Oncology (402 citations), Neurology (229 citations), Physiology (66 citations), Pulmonary and Respiratory Medicine (358 citations) and Cancer Research (128 citations). Catherine Labbé has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Natasha B. Leighl, John David Rioux, Kevin Jao, Pascale Tomasini, Owen A. Ross, Frances Alice Shepherd, Ramnik J. Xavier, Philippe Goyette, Geoffrey Liu and Gérard Maisse. Their work appears in journals such as Journal of Thoracic Oncology, Parkinsonism & Related Disorders, The Oncologist, Clinical Lung Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.